Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Treace Medical Concepts (TMCI) Other Operating Expenses (2020 - 2025)

Treace Medical Concepts (TMCI) has disclosed Other Operating Expenses for 6 consecutive years, with $88000.0 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Other Operating Expenses fell 25.42% year-over-year to $88000.0, compared with a TTM value of $432000.0 through Dec 2025, up 33.33%, and an annual FY2025 reading of $432000.0, up 33.33% over the prior year.
  • Other Operating Expenses was $88000.0 for Q4 2025 at Treace Medical Concepts, down from $92000.0 in the prior quarter.
  • Across five years, Other Operating Expenses topped out at $23.3 million in Q4 2021 and bottomed at -$357000.0 in Q4 2022.
  • Average Other Operating Expenses over 5 years is $3.3 million, with a median of $95500.0 recorded in 2023.
  • The sharpest move saw Other Operating Expenses plummeted 101.53% in 2022, then surged 6300.0% in 2023.
  • Year by year, Other Operating Expenses stood at $23.3 million in 2021, then tumbled by 101.53% to -$357000.0 in 2022, then soared by 126.89% to $96000.0 in 2023, then grew by 22.92% to $118000.0 in 2024, then dropped by 25.42% to $88000.0 in 2025.
  • Business Quant data shows Other Operating Expenses for TMCI at $88000.0 in Q4 2025, $92000.0 in Q3 2025, and $122000.0 in Q2 2025.